June 12, 2023
The U.S. Food and Drug Administration and the European Union are expanding their Mutual Recognition Agreement’s (MRA) Sectoral Annex for Pharmaceuticals Good Manufacturing Practices to include veterinary pharmaceuticals.
An MRA is an arrangement between two or more countries to acknowledge a specific process or procedure. The initial U.S. and EU MRA went into effect November 1, 2017, and included only pharmaceuticals intended for human use.
